Author of the publication

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

, , , , , and . Lancet Respiratory Medicine, (April 2021)
DOI: 10.1016/S2213-2600(21)00160-0